Aetna Inc. Stock
-
Your prediction
Pros and Cons of Aetna Inc. in the next few years
Pros
Cons
Performance of Aetna Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aetna Inc. | - | - | - | - | - | - | - |
| Centene Corp. | 0.620% | 2.231% | 6.768% | 100.835% | 66.999% | -6.418% | -7.616% |
| Humana Inc. | 0.000% | 0.585% | 13.158% | 70.550% | 56.648% | -15.062% | -10.370% |
| Cigna Corp. | 2.270% | 1.025% | -1.832% | -9.641% | 5.117% | -3.749% | 23.900% |
News
ARS Pharmaceuticals Q1 Earnings Call Highlights
ARS Pharmaceuticals (NASDAQ:SPRY) reported first-quarter 2026 revenue of $22.7 million as executives said the company is working to expand access, reduce prescribing friction and build momentum for
CVS Health Q1 Earnings Call Highlights
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with
Is CVS Health the Ultimate Value Stock to Buy Right Now?
Shares of CVS Health (NYSE: CVS) have lagged the S&P 500 in total return this year, reinforcing a familiar narrative about the healthcare company: a mature, slow-growing grinder.
However, that view


